The U.S. Food and Drug Administration (FDA) recently granted accelerated approval of a treatment for adults with metastatic ...

The WVU Rockefeller Neuroscience Institute (RNI) is providing patients greater statewide and regional access to a ...

While there's no cure yet for Alzheimer's, researchers are finally making more progress in better understanding the disease ...

New research suggests Alzheimer's drugs may improve cognition by increasing Aβ42 levels rather than just reducing plaques, ...

For spouses who care for a partner with Alzheimer’s disease, every day brings a different battle and a new challenge. Every ...

What time is it?” Cheryl Miller asks her husband, John. He wants to answer, but his wife has already asked him that question ...

FDA could also establish a more clear and transparent structure for interactions between agency staff and companies, which ...

Last July, the U.S. Food and Drug Administration (FDA) issued a notable approval for LEQEMBI ® (lecanemab-irmb), the first ...

The Schmitts agreed to receive a monthly infusion of Aducanumab, which is based on the same principle as Leqembi: It is an antibody, in this case from the U.S. biotechnology company Biogen.

In a clinical study, 16 radiologists read 199 retrospective MRI scans from the aducanumab Phase 2 and 3 trials either with or without the assistance of icobrain aria. The radiologists had an average ...

Just as Eisai notches wins in its campaign for lecanemab approval around the world—last month in the European Union, this week in Mexico—a dozen research and clinical leaders called on the U.S. FDA ...

From the beginning, the approval of its Aduhelm (aducanumab) treatment was met with controversy – over the interactions with the FDA, and the advisor committee’s vote against the treatment ...